Sign Up to like & get
recommendations!
1
Published in 2017 at "Journal of Neuroimmune Pharmacology"
DOI: 10.1007/s11481-017-9766-1
Abstract: Parkinson’s disease (PD) is a progressive movement disorder characterized by neuroinflammation and dopaminergic neurodegeneration in the brain. 1-methyl-4-phenylpyridinium (MPP+), a metabolite of the parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induces the release of inflammatory mediators from glial…
read more here.
Keywords:
mast cells;
inflammatory mediators;
glia neurons;
mast cell ... See more keywords